Literature DB >> 26507184

Associations Between Original and a Reduced Frontal Systems Behavior Scale (FrSBe), Cognition, and Activities of Daily Living in a Large Neurologic Sample.

Janessa O Carvalho1, Melissa T Buelow2, Rebecca E Ready3, Janet Grace4,5.   

Abstract

A recent confirmatory factor analysis (CFA) on the Frontal Systems Behavior Scale (FrSBe) indicated that the basic structure of the FrSBe subscales held after removal of 8 weak items. In a replication of previous studies using the original FrSBe, the present study explored associations between a reduced version of the FrSBe, cognition, and activities of daily living (ADLs) in a large mixed outpatient neurologic sample. Consistent with previous findings with the original FrSBe, significant associations existed between reduced FrSBe scores and the Mattis Dementia Rating Scale-Second Edition. Additionally, after controlling for age, gender, and education, reduced FrSBe Apathy was associated with basic ADLs, and reduced FrSBe Disinhibition was associated with instrumental ADLs. These results offer replication in a larger sample of previous findings and statistical support for a reduced FrSBe beyond CFA results alone.

Entities:  

Keywords:  assessment; behavioral dysfunction; neuropsychology

Mesh:

Year:  2015        PMID: 26507184     DOI: 10.1080/23279095.2015.1012759

Source DB:  PubMed          Journal:  Appl Neuropsychol Adult        ISSN: 2327-9095            Impact factor:   2.248


  2 in total

1.  Examining the Item-Level Factor Structure of the Behavior Rating Inventory of Executive Function-Adult Version Within a Traumatic Brain Injury Sample.

Authors:  Pey-Shan Wen; J Kay Waid-Ebbs; Shelley C Heaton; Amy K Starosciak; Sergio Gonzalez-Arias
Journal:  Arch Phys Med Rehabil       Date:  2021-08-08       Impact factor: 4.060

2.  Reduction in apathy following epilepsy surgery.

Authors:  Linda Mah; Joan Swearer; Catherine A Phillips; Sheldon Benjamin
Journal:  Neuropsychiatr Dis Treat       Date:  2019-06-28       Impact factor: 2.570

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.